Sponsor Pipeline

Gustavo A Heresi, MD, MS Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-11 NCT06992440
Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension		 overall status: Enrolling by Invitation → Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06992440 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension Recruiting
Disease Areas
Hypertension (1)
Get alerts when Gustavo A Heresi, MD, MS's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free